LONDON and CAMBRIDGE, MA--(MARKET WIRE)--Sep 25, 2007 -- InforSense Ltd., the leading provider of embedded enterprise intelligence, today announced that the University of North Carolina at Chapel Hill's Institute of Pharmacogenomics and Individualized Therapy (IPIT) has implemented the company's GenSense workflow-based analytics platform as an integral part of its research to better match medicines with patients' unique, individual needs.
